KRSA · Korsana Biosciences Inc
United States · RS rating 98 · As of 2026-10-14
| Price | 34.32 USD |
|---|---|
| 1-day change | +8.4% |
| RS rating (overall / 1M / 3M / 12M) | 98 / 91 / 94 / 96 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 41 / 53 / 29 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +23.1% |
| Market cap (USD) | $1.6B |